• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Evaluation of overall survival according to myelodysplastic syndrome-specific comorbidity index in a large series of myelodysplastic syndromes.在一大系列骨髓增生异常综合征中，根据骨髓增生异常综合征特异性合并症指数评估总生存期。
Haematologica. 2011 Oct;96(10):e41-2. doi: 10.3324/haematol.2011.048991.
2
Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.骨髓增生异常综合征和骨髓增生异常/骨髓增殖性肿瘤的风险评估
Haematologica. 2011 Mar;96(3):349-52. doi: 10.3324/haematol.2010.030023.
3
Progenitor cells and classification of myelodysplastic and myeloproliferative disorders.祖细胞与骨髓增生异常及骨髓增殖性疾病的分类
Lancet. 1985 Nov 30;2(8466):1240. doi: 10.1016/s0140-6736(85)90764-0.
4
Progenitor cells and classification of myelodysplastic and myeloproliferative disorders.祖细胞与骨髓增生异常和骨髓增殖性疾病的分类
Lancet. 1985 Oct 19;2(8460):885. doi: 10.1016/s0140-6736(85)90145-x.
5
Is chronic myelomonocytic leukemia more akin to myelodysplastic or myeloproliferative neoplasms and does it matter?慢性粒单核细胞白血病更类似于骨髓增生异常综合征还是骨髓增殖性肿瘤，这有关系吗？
Leuk Lymphoma. 2008 Jul;49(7):1225-7. doi: 10.1080/10428190802187189.
6
Studies on blood and bone marrow findings of myelodysplastic syndromes: evaluation of proposals for classification of myelodysplastic syndromes.
Proc Chin Acad Med Sci Peking Union Med Coll. 1988;3(1):7-11.
7
Topics in pediatric leukemia--myelodysplastic and myeloproliferative disorders of childhood.儿童白血病专题——儿童骨髓增生异常和骨髓增殖性疾病
MedGenMed. 2005 Mar 14;7(1):21.
8
The WHO classification of the myelodysplastic syndromes.世界卫生组织髓系发育异常综合征分类
Exp Oncol. 2004 Sep;26(3):166-9.
9
The myelodysplastic syndromes and myeloproliferative disorders.骨髓增生异常综合征和骨髓增殖性疾病
Clin Lab Sci. 2004 Fall;17(4):223-34.
10
The JAK2 V617F mutation is rare in RARS but common in RARS-T.JAK2 V617F突变在RARS中罕见，但在RARS-T中常见。
Leukemia. 2006 Nov;20(11):2060-1. doi: 10.1038/sj.leu.2404373. Epub 2006 Aug 24.

引用本文的文献

1
Patient stratification in myelodysplastic syndromes: how a puzzle may become a map.骨髓增生异常综合征的患者分层：谜题如何变成地图。
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):418-425. doi: 10.1182/hematology.2020000126.
2
Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV.合并症对慢性髓性白血病患者总生存的影响：随机CML研究IV的结果
Blood. 2015 Jul 2;126(1):42-9. doi: 10.1182/blood-2015-01-617993. Epub 2015 Apr 27.
3
The myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system.骨髓增生异常综合征合并症指数为根据修订的国际预后评分系统分层的患者提供了额外的预后信息。
Haematologica. 2014 Mar;99(3):e31-2. doi: 10.3324/haematol.2013.101055. Epub 2014 Jan 24.
4
There's risk, and then there's risk: The latest clinical prognostic risk stratification models in myelodysplastic syndromes.有风险，也有风险：骨髓增生异常综合征的最新临床预后风险分层模型。
Curr Hematol Malig Rep. 2013 Dec;8(4):351-60. doi: 10.1007/s11899-013-0172-3.
5
MDS-specific comorbidity index is useful to identify myelodysplastic patients who can have better outcome with 5-azacitidine.骨髓增生异常综合征特异性合并症指数有助于识别使用5-氮杂胞苷可能有更好预后的骨髓增生异常患者。
Haematologica. 2012 Feb;97(2):e2. doi: 10.3324/haematol.2011.059808.

本文引用的文献

1
Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.骨髓增生异常综合征和骨髓增生异常/骨髓增殖性肿瘤的风险评估
Haematologica. 2011 Mar;96(3):349-52. doi: 10.3324/haematol.2010.030023.
2
Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome.基于疾病状态和骨髓增生异常综合征患者的血液外合并症的风险分层。
Haematologica. 2011 Mar;96(3):441-9. doi: 10.3324/haematol.2010.033506. Epub 2010 Dec 6.
3
Evaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patients.诊断时合并症的评估可预测骨髓增生异常综合征患者的预后。
Leuk Res. 2011 Feb;35(2):159-62. doi: 10.1016/j.leukres.2010.06.005. Epub 2010 Jul 1.
4
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.用于预测骨髓增生异常综合征患者生存及白血病演变的时间依赖性预后评分系统。
J Clin Oncol. 2007 Aug 10;25(23):3503-10. doi: 10.1200/JCO.2006.08.5696.

Evaluation of overall survival according to myelodysplastic syndrome-specific comorbidity index in a large series of myelodysplastic syndromes.

作者信息

Breccia Massimo, Federico Vincenzo, Loglisci Giuseppina, Salaroli Adriano, Serrao Alessandra, Alimena Giuliana

出版信息

Haematologica. 2011 Oct;96(10):e41-2. doi: 10.3324/haematol.2011.048991.

DOI:10.3324/haematol.2011.048991
PMID:21972212
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3186296/
Abstract
摘要